Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer

被引：0
|
作者：
Shen, Yijun
Peng, Liangju
Xu, Peihang
Wang, Yanhao
Wang, Xiang
Yao Xudong
Liu, Yushan
Ye, Ding-Wei
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4594
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer
    Zahoor, Haris
    Mir, Maria C.
    Barata, Pedro C.
    Stephenson, Andrew J.
    Campbell, Steven C.
    Fergany, Amr
    Dreicer, Robert
    Garcia, Jorge A.
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (06) : 1231 - 1238
  • [32] Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer
    Haris Zahoor
    Maria C. Mir
    Pedro C. Barata
    Andrew J. Stephenson
    Steven C. Campbell
    Amr Fergany
    Robert Dreicer
    Jorge A. Garcia
    Investigational New Drugs, 2019, 37 : 1231 - 1238
  • [33] Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
    Marquette, T.
    Walz, J.
    Rybikowski, S.
    Maubon, T.
    Branger, N.
    Fakhfakh, S.
    Verde, K. L.
    Dermeche, S.
    Gravis, G.
    Pignot, G.
    PROGRES EN UROLOGIE, 2020, 30 (01): : 35 - 40
  • [34] Pembrolizumab for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG): Phase II KEYNOTE-057 trial
    de Wit, R.
    Kulkarni, G. S.
    Uchio, E.
    Singer, E. A.
    Krieger, L.
    Grivas, P.
    Bajorin, D.
    Seo, H. K.
    Mourey, L.
    Kamat, A.
    Nishiyama, H.
    Kapadia, E.
    Nam, K.
    Frenkl, T.
    Balar, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 304 - 304
  • [35] LATE CELL CYCLE SIGNATURES STRATIFY GEMDOCE RESPONSES FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Gabrielson, Andrew
    Epstein, Gabriel
    Feng, Mingxiao
    Patel, Sunil
    Kates, Max
    Choi, Woonyoung
    JOURNAL OF UROLOGY, 2023, 209 : E188 - E189
  • [36] Association of BCG shortage with bladder cancer recurrence in high-risk non-muscle invasive bladder cancer
    Lee, Sangmin
    Lim, Bumjin
    You, Dalsan
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    Jeong, In Gab
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 26 - 27
  • [37] BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
    Cedric Lebacle
    Yohann Loriot
    Jacques Irani
    World Journal of Urology, 2021, 39 : 4037 - 4046
  • [38] AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS)
    Kulkarni, Girish
    Richards, Kyle
    Black, Peter C.
    Rendon, Ricardo
    Chin, Joseph
    Shore, Neal
    Jayram, Gautam
    Kramolowsky, Eugene
    Saltzstein, Daniel
    Agarwal, Piyush
    Belkoff, Laurence
    O'Donnell, Michael
    Kamat, Ashish M.
    Zlotta, Alexandre
    Jewett, Michael A. S.
    Lamm, Donald
    DeGruttola, Victor
    Mandel, Arkady
    Dumoulin-White, Roger J.
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2023, 209 : E871 - E871
  • [39] BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
    Lebacle, Cedric
    Loriot, Yohann
    Irani, Jacques
    WORLD JOURNAL OF UROLOGY, 2021, 39 (11) : 4037 - 4046
  • [40] A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.
    Hahn, Noah M.
    Chang, Sam S.
    Meng, Maxwell
    Shore, Neal D.
    Konety, Badrinath R.
    Steinberg, Gary D.
    Gschwend, Juergen E.
    Nishiyama, Hiroyuki
    Redorta, Juan Palou
    Taylor, John Arthur
    Elegbe, Ayanbola
    Lambert, Alexandre
    Zhu, Li
    Ishii, Yuko
    Maeda, Toshiki
    Raybold, Bradley
    Grossfeld, Gary
    Fischer, Bruce S.
    Rutstein, Mark
    Witjes, Alfred
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345